Total Payments
$9,433
2022 Payments
$898.60
Companies
53
Transactions
521
Medicare Patients
1,452
Medicare Billing
$93,139
Payment Breakdown by Category
Food & Beverage$9,341 (99.0%)
Education$77.69 (0.8%)
Other$14.63 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,341 | 512 | 99.0% |
| Education | $77.69 | 8 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.63 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,338 | 45 | $0 (2021) |
| PFIZER INC. | $1,121 | 67 | $0 (2022) |
| ABBVIE INC. | $823.49 | 55 | $0 (2022) |
| Allergan, Inc. | $732.34 | 77 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $608.97 | 34 | $0 (2022) |
| Astellas Pharma US Inc | $559.73 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $388.73 | 16 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $348.21 | 15 | $0 (2022) |
| Alkermes, Inc. | $334.29 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $231.66 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $898.60 | 46 | ABBVIE INC. ($234.20) |
| 2021 | $1,413 | 90 | AbbVie Inc. ($481.24) |
| 2020 | $1,001 | 57 | PFIZER INC. ($288.24) |
| 2019 | $1,913 | 109 | Janssen Pharmaceuticals, Inc ($240.86) |
| 2018 | $1,798 | 106 | Janssen Pharmaceuticals, Inc ($285.05) |
| 2017 | $2,409 | 113 | Janssen Pharmaceuticals, Inc ($619.60) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $106.45 | General |
| Category: CNS | ||||||
| 10/13/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $103.09 | General |
| Category: CNS | ||||||
| 07/08/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Gastroenterology | ||||||
| 06/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: DIABETES | ||||||
| 06/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 05/20/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Cardiovascular | ||||||
| 05/13/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.21 | General |
| 05/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Diabetes | ||||||
| 04/29/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PSYCHIATRY | ||||||
| 04/15/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Urology | ||||||
| 04/12/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 04/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2022 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 293 | 333 | $46,866 | $16,988 |
| 2021 | 13 | 612 | 807 | $108,675 | $42,540 |
| 2020 | 11 | 547 | 763 | $112,801 | $33,611 |
Total Patients
1,452
Total Services
1,903
Medicare Billing
$93,139
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $11,250 | $7,048 | 62.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 94 | $15,510 | $4,301 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 50 | $11,250 | $3,264 | 29.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 47 | 47 | $2,350 | $947.16 | 40.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 20 | $2,000 | $503.88 | 25.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $600.00 | $388.47 | 64.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 32 | 33 | $2,475 | $273.34 | 11.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 27 | $1,431 | $260.87 | 18.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 216 | $35,640 | $13,861 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 145 | $32,625 | $12,927 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 54 | 54 | $12,150 | $7,717 | 63.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 25 | 25 | $2,250 | $1,661 | 73.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 38 | $3,800 | $1,318 | 34.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 52 | 52 | $2,600 | $1,063 | 40.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 93 | 95 | $7,125 | $989.13 | 13.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 34 | 82 | $4,346 | $796.22 | 18.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 13 | 15 | $3,000 | $617.21 | 20.6% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 13 | 13 | $2,015 | $570.96 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $1,300 | $481.78 | 37.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 18 | 18 | $900.00 | $333.54 | 37.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 24 | 28 | $924.00 | $204.23 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 257 | $42,405 | $13,334 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 164 | 177 | $39,825 | $10,979 | 27.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 14 | 14 | $7,210 | $2,963 | 41.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 27 | 27 | $2,430 | $1,647 | 67.8% |
About Dr. Frederick Pope, MD
Dr. Frederick Pope, MD is a Internal Medicine healthcare provider based in Wethersfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912984618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Pope, MD has received a total of $9,433 in payments from pharmaceutical and medical device companies, with $898.60 received in 2022. These payments were reported across 521 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,341).
As a Medicare-enrolled provider, Pope has provided services to 1,452 Medicare beneficiaries, totaling 1,903 services with total Medicare billing of $93,139. Data is available for 3 years (2020–2022), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wethersfield, CT
- Active Since 12/23/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912984618
Products in Payments
- INVOKANA (Drug) $755.52
- VRAYLAR (Drug) $654.05
- XARELTO (Drug) $576.71
- FARXIGA (Drug) $553.70
- CHANTIX (Drug) $404.41
- JARDIANCE (Drug) $360.52
- UBRELVY (Drug) $351.11
- ENTRESTO (Drug) $348.21
- XIFAXAN (Drug) $282.23
- MYRBETRIQ (Drug) $280.55
- ELIQUIS (Drug) $250.81
- LYBALVI (Drug) $209.54
- Trintellix (Drug) $194.25
- Vascepa (Drug) $193.34
- Myrbetriq (Drug) $192.81
- EUCRISA (Drug) $169.64
- Aimovig (Biological) $162.34
- TRULICITY (Drug) $143.98
- LYRICA (Drug) $134.35
- REXULTI (Drug) $131.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wethersfield
Komsu Mamuya, Md, MD
Internal Medicine — Payments: $43,005
Internal Medicine $43,005
Dr. Scott Walker, M.d, M.D
Internal Medicine — Payments: $9,291
Internal Medicine $9,291
Wayne Paulekas, Md, MD
Internal Medicine — Payments: $5,491
Internal Medicine $5,491
Anne Pinou, Md, MD
Internal Medicine — Payments: $4,291
Internal Medicine $4,291
Robert Reginio, Md, MD
Internal Medicine — Payments: $996.29
Internal Medicine $996.29
Dr. Thomas Brown, M.d, M.D
Internal Medicine — Payments: $506.56
Internal Medicine $506.56